Equities

Theralase Technologies Inc

Theralase Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (CAD)0.16
  • Today's Change0.00 / 0.00%
  • Shares traded38.85k
  • 1 Year change-30.43%
  • Beta1.5956
Data delayed at least 15 minutes, as of May 03 2024 18:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Theralase Technologies Inc (TLT:CVE) closed at 0.16, 6.67% above its 52-week low of 0.150, set on Apr 29, 2024.
52-week range
Today
0.150Apr 29 20240.31Jul 12 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.165
High0.165
Low0.16
Bid0.16
Offer0.165
Previous close0.16
Average volume57.98k
Shares outstanding223.14m
Free float199.66m
P/E (TTM)--
Market cap35.70m CAD
EPS (TTM)-0.0209
CAD
Data delayed at least 15 minutes, as of May 03 2024 18:05 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.